期刊文献+

埃索美拉唑联合莫沙必利治疗反流性食管炎46例 被引量:8

下载PDF
导出
摘要 目的观察埃索美拉唑联合莫沙必利治疗反流性食管炎的疗效。方法将92例患者随机均分为两组。治疗组46例给予埃索美拉唑40 mg,每日1次,晨起口服;莫沙必利5 mg,每日3次,餐前30 min口服。对照组46例给予奥美拉唑20 mg,每日2次,口服;西沙必利10 mg,每日3次,口服。疗程均为4周,观察两组疗效和不良反应。结果治疗组临床总有效率和内镜检查显效率、总有效率均明显高于对照组(P<0.05)。结论埃索美拉唑联合莫沙必利治疗反流性食管炎疗效确切,无明显不良反应,值得临床推广应用。
作者 龙彦
出处 《中国药业》 CAS 2012年第3期59-59,共1页 China Pharmaceuticals
  • 相关文献

参考文献3

二级参考文献17

  • 1王静,侯晓华.埃索美拉唑的临床应用进展[J].胃肠病学,2003,8(2):125-126. 被引量:39
  • 2ROHSS K, WILDER-SMITH C H, CLARR-NILSSON C, et al. Esomeprazole 40 mg provides more effective acid control than standard doses of all other proton pump inhibitor[J]. Gastroenterology, 2001,120 (Suppl 5) : 154- 154.
  • 3THOMSON A B R,CLAAR-NILSSON C. Esomeprazole 40 mg provides more effective acid control than lansoprozole 30 mg during single and repeated administration [JJ. Gut, 2000,47(Supp13) : 63-63.
  • 4WILDER-SMITH C , ROHSS K, RYDHOLM H, et al. Esomeprazole 40 mg provides more effective acid control than rebeprozole 20 mg[J] Gut, 2000,47 (Suppl 3) :A63-63.
  • 5SCOTT L J, DUNN C H J, MALLARKEY G, et al. Esomeprazole : a review of its use in the management of acid-related disorders in the US [J]. Drugs ,2002, 62:1091-1118.
  • 6CASTELL D O , FENNERTY M B , JOHNSON D A, et al. A critical analysis of the new PPI esomeprazole [J]. AGA New Dew Drug Review , 2001,1 : 1 -19.
  • 7KAHRILAS P J, FALK G W, JOHNSON D A, et al. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial[J]. Aliment Pharmacol Ther ,2000, 14:1249-1258.
  • 8RICHTER J E, KAHRILAS P J , JOHANSON J , et al. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis:a randomized controlled trial[J]. Am J Gastroenterol,2001, 96 .656-665.
  • 9JOHNSON D A, BENJAMIN S B ,VAKIL N B, et al. Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms : a randomized double-blind , placebo-controlled study of efficacy and safety[J]. Am J Gastroentarol , 2001, 96:27-34.
  • 10LIND T, RYDBERG L ,KYLEBACK A ,et al. Esomeprazole prpvides improved acid control vs . omeprazole in patients with symptoms of gastro-oesophaged reflux disease [J]. Aliment Pharmacol Ther , 2000,14:861-867.

共引文献35

同被引文献59

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部